Purchase Order 75N91024P00496

This $17,053.58 firm fixed price purchase order was awarded by the National Cancer Institute (NCI), a civilian agency, to an undisclosed prime contractor on September 11, 2024. The contract is for a service agreement with a period of performance through March 10, 2025. No set-aside designation is indicated. The contract award does not provide details about the specific products or services to be delivered, but as the NCI is the funding agency, the work is likely related to the institute's cancer...

The National Cancer Institute awarded a purchase order to Arraystar Inc. for $22,176.00 on June 14, 2021, for lab testing services. Work is performed in Rockville, Maryland. The order is firm fixed price with an ultimate completion date of July 14, 2021. The purchase order was issued to administratively de-obligate unexpended and expiring fiscal year 2021 funding in accordance with 31 U.S.C. Section 1552(a) in preparation for the September 30, 2026 closing of the period of availability of...

<p>This is a firm fixed-price purchase order awarded by the National Cancer Institute, a civilian agency, to the National Cancer Center, National Research and Development Agency in Japan. The contract is for $24,000.00 and covers laboratory testing services for the National Cancer Center. The performance period runs from the award date of May 16, 2025 through the ultimate completion date of September 15, 2025. This contract does not have a set-aside designation.</p>

<p>The National Cancer Institute awarded a purchase order to Northeastern University valued at $19,345.00 on May 15, 2020, for professional services. Place of performance is Bethesda, Maryland. The order carries a firm fixed-price structure with an ultimate completion date of December 31, 2020. No set-aside was used.</p>

<p>This firm-fixed-price purchase order was awarded by the National Cancer Institute, a civilian federal agency, to Abiosciences Inc. for $14,000.00 to provide lab testing services. The award has an ultimate completion date of October 25, 2024 and was made on June 26, 2024. No set-aside designation is mentioned. The contract does not appear to be associated with a larger vehicle.</p>

<p>The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a firm fixed-price purchase order to C S Bio Co., a Minority Owned Business, Subchapter S Corporation, for $18,175.00 in laboratory testing services. The contract has an anticipated completion date of August 31, 2024 and was awarded on April 1, 2024. The services will be performed in Bethesda, Maryland. No set-aside was used for this award.</p>

<p>This is a federal contract award from the National Cancer Institute, a civilian agency within the U.S. Department of Health and Human Services, to a prime contractor. The contract has a ceiling value of $679,333.47 and was awarded on August 19, 2016 with a final completion date of September 14, 2020. The contract is a Delivery Order with a Cost Plus Fixed Fee pricing type. The place of performance is Columbia, MD. The contract does not have a set-aside designation.</p>

<p>The National Cancer Institute issued a delivery order to Westat, Inc. on July 27, 2025, with a ceiling value of $12,927,918 for scientific support services to the Division of Cancer Control and Population Sciences (DCCPS) through July 26, 2026.</p> <p>Place of performance is Rockville, MD. The order is firm fixed price. Performance is scheduled to conclude on July 26, 2027.</p>

<p>The National Cancer Institute awarded a purchase order to Genepria Consulting Inc. for $15,000.00 on August 2, 2019, for laboratory services. The order carries no set-aside designation. Place of performance is Columbia, Maryland. The period of performance runs from August 2, 2019, through August 1, 2020, under firm fixed-price terms.</p>

The Department of Health and Human Services National Institutes of Health National Cancer Institute (HHS-NIH-NCI) awarded a $16,265 purchase order to Capralogics Inc. for testing services. The firm fixed price contract will be performed in Hardwick, Massachusetts over a three-month period from July 1, 2023 through September 30, 2023. As the intramural research program of the NCI, a component of the NIH focused on cancer research, this contract supports the agency's mission to lead the nation's...